LABU vs. BIB
Compare and contrast key facts about Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Nasdaq Biotechnology (BIB).
LABU and BIB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015. BIB is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (200%). It was launched on Apr 7, 2010. Both LABU and BIB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LABU or BIB.
Correlation
The correlation between LABU and BIB is 0.58, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
LABU vs. BIB - Performance Comparison
Key characteristics
LABU:
-0.45
BIB:
-0.11
LABU:
-0.21
BIB:
0.12
LABU:
0.97
BIB:
1.02
LABU:
-0.37
BIB:
-0.07
LABU:
-1.20
BIB:
-0.29
LABU:
30.50%
BIB:
16.40%
LABU:
80.72%
BIB:
41.39%
LABU:
-99.18%
BIB:
-67.24%
LABU:
-98.77%
BIB:
-57.96%
Returns By Period
In the year-to-date period, LABU achieves a -37.42% return, which is significantly lower than BIB's -8.97% return.
LABU
-37.42%
-26.02%
-53.37%
-36.92%
-41.65%
N/A
BIB
-8.97%
-11.81%
-24.71%
-6.65%
-5.61%
-5.37%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABU vs. BIB - Expense Ratio Comparison
LABU has a 1.12% expense ratio, which is higher than BIB's 0.95% expense ratio.
Risk-Adjusted Performance
LABU vs. BIB — Risk-Adjusted Performance Rank
LABU
BIB
LABU vs. BIB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bull 3x Shares (LABU) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LABU vs. BIB - Dividend Comparison
LABU's dividend yield for the trailing twelve months is around 0.46%, less than BIB's 2.05% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.46% | 0.35% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
BIB ProShares Ultra Nasdaq Biotechnology | 2.05% | 1.69% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
LABU vs. BIB - Drawdown Comparison
The maximum LABU drawdown since its inception was -99.18%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for LABU and BIB. For additional features, visit the drawdowns tool.
Volatility
LABU vs. BIB - Volatility Comparison
Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a higher volatility of 45.73% compared to ProShares Ultra Nasdaq Biotechnology (BIB) at 24.41%. This indicates that LABU's price experiences larger fluctuations and is considered to be riskier than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.